Inspire Medical Systems (INSP) closed at $64.14 on Aug 4, 2026, up 22.8% on the day. The stock is up 29.7% over the past month, up 17.0% over three months, down 30.5% year to date and down 50.6% over the past year (since Aug 4, 2025). It trades 56.4% below its 52-week high of $147.03 and 64.8% above its 52-week low of $38.91. The close sits above its 50-day moving average ($46.50) and below its 200-day moving average ($68.57).
INSP options were pricing 71% at-the-money implied volatility on Oct 29, 2026, an IV rank of 34 over the past year.
No — the Aug 4, 2026 close of $64.14 is 6.5% below the 200-day average of $68.57.
INSP closed 56.4% below its 52-week high of $147.03.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
